Physician profile
Simon Becker
NPI 1982605697
$4,843.47
in general payments reported to CMS, 2019-2025
28 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $250 · 2021: $1,070 · 2022: $159 · 2023: $238 · 2024: $2,326 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,449 · Travel and Lodging: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,449.05 |
| Travel and Lodging | $1,296.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $2,192.08 | 2023-2024 | |
| Treace Medical Concepts, INC. | $1,031.19 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $370.87 | 2021-2025 | Nuzyra |
| Stryker Corporation | $260.74 | 2019-2023 | Easyfuse, Citrefix |
| Melinta Therapeutics, LLC | $134.29 | 2019 | |
| Smith+Nephew, INC. | $114.68 | 2019-2021 | |
| Sandoz INC. | $112.39 | 2019-2021 | |
| Crossroads Extremity Systems, LLC | $111.84 | 2020 | |
| Horizon Therapeutics Plc | $90.21 | 2019-2023 | Krystexxa |
| Nabriva Therapeutics, Plc | $39.21 | 2020-2022 | |
| Bone Support INC. | $37.40 | 2024 | Cerament G, Ceramentbone Void Filler |
| Organogenesis INC. | $34.53 | 2021 | |
| Wright Medical Technology, INC. | $30.72 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $30.12 | 2022-2023 | Jublia |
| Depuy Synthes Sales INC. | $25.98 | 2024 | N/A |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $25.30 | 2022 | |
| Nevro Corp. | $23.98 | 2023 | Senza |
| Bioventus LLC | $23.13 | 2019 | |
| Abbott Laboratories | $23.13 | 2019 | |
| Orthofix Medical, INC. | $20.79 | 2025 | Physio-Stim |
| Grt US Holding, INC. | $17.47 | 2021 | |
| Abbvie INC. | $17.36 | 2022 | |
| Sebela Pharmaceuticals INC. | $15.00 | 2020 | |
| Zyla Life Sciences, INC. | $13.58 | 2019 | |
| Pfizer INC. | $13.10 | 2019 | |
| Medtronic USA, INC. | $11.95 | 2020 | |
| Dynasplint Systems INC. | $11.90 | 2019 | |
| Next Science LLC | $10.53 | 2023 | Xperience, Blastx, Surgx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.